MAR 07, 2025 1:00 PM PST

Advances in Ovarian cancer diagnostics: The role of ROMA, CA 125 and HE4

Sponsored by: Abbott
Speaker

Event Date & Time
Date: March 7, 2025
Time: 1:00 PM (PST), 4:00 PM (EST), 10:00 PM (CET)
Abstract
Ovarian cancer remains a significant challenge in women's health, with high mortality rates due to late-stage diagnosis. This webinar aims to provide healthcare professionals with an in-depth understanding of the current landscape of ovarian cancer diagnostics, focusing on the utility of the Risk of Ovarian Malignancy Algorithm (ROMA) and the biomarkers CA125 and HE4.
 
The session will begin with an overview of the ovarian cancer landscape today, highlighting epidemiological data, and survival rates. Despite advancements in treatment, ovarian cancer continues to have a poor prognosis, particularly in advanced stages. The webinar will address the limitations of traditional diagnostic methods and the importance of integrating novel biomarkers and algorithms to improve diagnostic accuracy and patient outcomes.
 
By the end of this webinar, participants will have a comprehensive understanding of how to leverage CA125, HE4, and ROMA in their clinical workflow.
 
Learning Objectives
  • Define the Current Landscape of Ovarian Cancer
  • Recognize clinical utility of Key Biomarkers (CA125 and HE4) and the ROMA Algorithm
  • Integrate Advanced Diagnostic Tools into Clinical Practice
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 
 

You May Also Like
Loading Comments...
Event Countdown
  • 0 Days
  • 0 Hours
  • 0 Minutes
  • 0 Seconds
Attendees